EMD Emyria Commences National Expansion with Avive in Brisbane 29/07/25 PRICE SENSITIVE download Created with Sketch. 769.48KB Share EMD June 2025 Quarterly Activities Report and Appendix 4C 28/07/25 PRICE SENSITIVE download Created with Sketch. 1.84MB Share EMD Medibank to Fund Emyria's PTSD Program at Perth Clinic 18/06/25 PRICE SENSITIVE download Created with Sketch. 433.29KB Share EMD Trading Halt 16/06/25 PRICE SENSITIVE download Created with Sketch. 473.05KB Share EMD PTSD Gains Sustained at 6m Follow-Up, MOU Signed with ANU 28/05/25 PRICE SENSITIVE download Created with Sketch. 897.65KB Share EMD March 2025 Quarterly Activities Report and Appendix 4C 29/04/25 PRICE SENSITIVE download Created with Sketch. 1.73MB Share EMD Emyria Opens New Empax Centre to Meet Demand and Payer Needs 14/04/25 PRICE SENSITIVE download Created with Sketch. 448.65KB Share EMD Appendix 4D and Half Year End Financial Report 27/02/25 PRICE SENSITIVE download Created with Sketch. 580.6KB Share EMD Emyria Reports Promising 3-Month PTSD Treatment Results 04/02/25 PRICE SENSITIVE download Created with Sketch. 1.7MB Share EMD December 2024 Quarterly Activities Report and Appendix 4C 31/01/25 PRICE SENSITIVE download Created with Sketch. 2.12MB Share EMD Leadership Updates 22/01/25 PRICE SENSITIVE download Created with Sketch. 1.24MB Share EMD Emyria Secures $2.525M in Strongly Supported Placement 27/11/24 PRICE SENSITIVE download Created with Sketch. 575.49KB Share EMD Trading Halt 25/11/24 PRICE SENSITIVE download Created with Sketch. 700.01KB Share EMD Response to ASX Price Query 12/11/24 PRICE SENSITIVE download Created with Sketch. 968.47KB Share EMD Emyria & UWA Partner to License Novel Serotonin Therapies 31/10/24 PRICE SENSITIVE download Created with Sketch. 352.8KB Share EMD September 2024 Quarterly Activities Report and Appendix 4C 30/10/24 PRICE SENSITIVE download Created with Sketch. 1.5MB Share EMD Emyria Gains Ethics Endorsement for Psilocybin Program 28/10/24 PRICE SENSITIVE download Created with Sketch. 459.76KB Share EMD Emyria Shares Interim Success in PTSD Treatment Program 02/09/24 PRICE SENSITIVE download Created with Sketch. 620.03KB Share EMD Appendix 4E & Annual Report for the Year Ended 30 June 2024 30/08/24 PRICE SENSITIVE download Created with Sketch. 1.15MB Share EMD June 2024 Quarterly Activities Report and Appendix 4C 30/07/24 PRICE SENSITIVE download Created with Sketch. 2.74MB Share EMD Emyria, UWA Secure $499K Grant for MDMA Analogue Program 01/07/24 PRICE SENSITIVE download Created with Sketch. 352.93KB Share EMD Empax Centre Selected As Key Site In Global PTSD Study 20/06/24 PRICE SENSITIVE download Created with Sketch. 459.81KB Share EMD March 2024 Quarterly Activities Report and Appendix 4C 26/04/24 PRICE SENSITIVE download Created with Sketch. 516.19KB Share EMD Emyria Receives Bids of $2.3M to Expand Clinical Services 23/04/24 PRICE SENSITIVE download Created with Sketch. 674.43KB Share EMD Trading Halt 19/04/24 PRICE SENSITIVE download Created with Sketch. 779.23KB Share EMD Emyria Opens Empax Centre to Advance Mental Health Care 10/04/24 PRICE SENSITIVE download Created with Sketch. 1.92MB Share EMD Emyria Expands Specialist AP Team - First Female for MDMA-AT 05/04/24 PRICE SENSITIVE download Created with Sketch. 449.97KB Share EMD Emyria, Reach Wellness Enter MDMA-AT Research Agreement 03/04/24 PRICE SENSITIVE download Created with Sketch. 688.66KB Share EMD Response to ASX Aware Query 12/03/24 PRICE SENSITIVE download Created with Sketch. 1014.06KB Share EMD Response to ASX Price Query 08/03/24 PRICE SENSITIVE download Created with Sketch. 962.69KB Share EMD Appendix 4D and Half Year End Financial Report 28/02/24 PRICE SENSITIVE download Created with Sketch. 979.17KB Share EMD December 2023 Quarterly Activities Report and Appendix 4C 31/01/24 PRICE SENSITIVE download Created with Sketch. 1.26MB Share EMD Emyria Receives $2.5M R&D Tax Incentive Refund 15/01/24 PRICE SENSITIVE download Created with Sketch. 326.75KB Share EMD Emyria Specialist Granted Authorised Prescriber Status 10/01/24 PRICE SENSITIVE download Created with Sketch. 786.2KB Share EMD Board Changes and Executive Restructuring 13/11/23 PRICE SENSITIVE download Created with Sketch. 714.67KB Share EMD Emyria Secures Ethics Endorsement for MDMA AP Application 30/10/23 PRICE SENSITIVE download Created with Sketch. 453.79KB Share EMD September 2023 Quarterly Activities Report and Appendix 4C 26/10/23 PRICE SENSITIVE download Created with Sketch. 2.01MB Share EMD Health Canada Approval Received for MDMA Import 19/10/23 PRICE SENSITIVE download Created with Sketch. 708.64KB Share EMD Emyria's Clinic Achieves Key MDMA-AT Dosing Milestone 09/10/23 PRICE SENSITIVE download Created with Sketch. 764.02KB Share EMD Completion of Entitlement Offer 05/10/23 PRICE SENSITIVE download Created with Sketch. 784.09KB Share EMD Emyria Secures Local MDMA to Start PTSD Trial Dosing 21/09/23 PRICE SENSITIVE download Created with Sketch. 770.68KB Share EMD Emyria Completes Acquisition of the Pax Centre 13/09/23 PRICE SENSITIVE download Created with Sketch. 763.21KB Share EMD Strategic Update & Entitlement Offer Presentation 06/09/23 PRICE SENSITIVE download Created with Sketch. 9.15MB Share EMD Prospectus 06/09/23 PRICE SENSITIVE download Created with Sketch. 635.86KB Share EMD Emyria Gets $2M Bids, Sets $3.1M Entitlement Offer 04/09/23 PRICE SENSITIVE download Created with Sketch. 854.7KB Share EMD Trading Halt 31/08/23 PRICE SENSITIVE download Created with Sketch. 723.52KB Share EMD Appendix 4E Preliminary Financial Report 30/08/23 PRICE SENSITIVE download Created with Sketch. 253.14KB Share EMD Emyria Launches Ketamine-Assisted Therapy Program 08/08/23 PRICE SENSITIVE download Created with Sketch. 1.22MB Share EMD June 2023 Quarterly Activities Report and Appendix 4C 31/07/23 PRICE SENSITIVE download Created with Sketch. 773.99KB Share EMD Emyria Recruits First Patient MDMA-Assisted Therapy Trial 10/07/23 PRICE SENSITIVE download Created with Sketch. 925.91KB Share EMD Presentation - Pax Acquisition and Company Update 06/07/23 PRICE SENSITIVE download Created with Sketch. 7.92MB Share EMD Pax Centre Acquisition to Advance Psychedelic Therapies 03/07/23 PRICE SENSITIVE download Created with Sketch. 1.1MB Share EMD Trading Halt 29/06/23 PRICE SENSITIVE download Created with Sketch. 374.84KB Share EMD Emyria Receives Ethics Approval for MDMA-assisted Therapy 08/06/23 PRICE SENSITIVE download Created with Sketch. 717.18KB Share EMD Emyria Completes $2.5m Placement 01/05/23 PRICE SENSITIVE download Created with Sketch. 630.65KB Share EMD March 2023 Quarterly Activities Report and Appendix 4C 28/04/23 PRICE SENSITIVE download Created with Sketch. 815.17KB Share EMD Trading Halt 27/04/23 PRICE SENSITIVE download Created with Sketch. 700.42KB Share EMD Emyria Unveils Highest Potency CBD Capsule for FDA Pathway 24/04/23 PRICE SENSITIVE download Created with Sketch. 631.36KB Share EMD Emyria to Develop Psilocybin Therapy Care Model 18/04/23 PRICE SENSITIVE download Created with Sketch. 1.16MB Share EMD Emyria, Aspen Sign Binding Commercial Term Sheet for EMD-RX5 04/04/23 PRICE SENSITIVE download Created with Sketch. 1.16MB Share EMD Strong Recruitment for EMD-RX5 Phase 3 Trial 23/03/23 PRICE SENSITIVE download Created with Sketch. 1.19MB Share EMD Emyria Grows MDMA Asset for Neuro & Mental Health Therapy 20/03/23 PRICE SENSITIVE download Created with Sketch. 638.15KB Share EMD Emyria partners with PAX Centre for MDMA-assisted therapy 07/03/23 PRICE SENSITIVE download Created with Sketch. 627.19KB Share EMD Half Yearly Report and Accounts 27/02/23 PRICE SENSITIVE download Created with Sketch. 1.65MB Share EMD Emyria secures clinical-grade MDMA supply for Aust patients 13/02/23 PRICE SENSITIVE download Created with Sketch. 544.06KB Share EMD Emyria expands MDMA programs following landmark TGA decision 06/02/23 PRICE SENSITIVE download Created with Sketch. 1.81MB Share EMD Appendix 4C - Quarterly 31/01/23 PRICE SENSITIVE download Created with Sketch. 742.38KB Share EMD First dosing commenced for pivotal EMD-RX5 Phase 3 trial 30/01/23 PRICE SENSITIVE download Created with Sketch. 959.35KB Share EMD Emyria receives $2.1M R&D tax incentive refund 12/01/23 PRICE SENSITIVE download Created with Sketch. 526.56KB Share EMD Emyria accepted into National Institutes of Health Program 28/11/22 PRICE SENSITIVE download Created with Sketch. 636.11KB Share EMD Placement completion and secondary trading notice 23/11/22 PRICE SENSITIVE download Created with Sketch. 526.8KB Share EMD Appendix 4C - Quarterly 31/10/22 PRICE SENSITIVE download Created with Sketch. 861.3KB Share EMD Emyria completes $3m placement 31/10/22 PRICE SENSITIVE download Created with Sketch. 540.33KB Share EMD Trading Halt 27/10/22 PRICE SENSITIVE download Created with Sketch. 675.01KB Share EMD Emyria and UWA expand unique MDMA-inspired analogue library 18/10/22 PRICE SENSITIVE download Created with Sketch. 535.12KB Share EMD Emyria expands clinical sites for EMD-RX5 Phase 3 trial 26/09/22 PRICE SENSITIVE download Created with Sketch. 306.61KB Share EMD Emyria commences US preclinical program for MDMA library 19/09/22 PRICE SENSITIVE download Created with Sketch. 524.42KB Share EMD Appendix 4E and Annual Report 29/08/22 PRICE SENSITIVE download Created with Sketch. 1.78MB Share EMD Positive results received for Emyrias MDMA-inspired program 18/08/22 PRICE SENSITIVE download Created with Sketch. 315.32KB Share EMD Emyria receives ethics approval for EMD-RX5 Phase 3 trial 16/08/22 PRICE SENSITIVE download Created with Sketch. 155.53KB Share EMD Preclinical studies initiated for MDMA-inspired analogues 04/08/22 PRICE SENSITIVE download Created with Sketch. 157.16KB Share EMD Appendix 4C - Quarterly 28/07/22 PRICE SENSITIVE download Created with Sketch. 776.97KB Share EMD Emyria expands drug candidate library inspired by MDMA 18/07/22 PRICE SENSITIVE download Created with Sketch. 161.97KB Share EMD Emyria expands MDMA analogue program with UWA 31/05/22 PRICE SENSITIVE download Created with Sketch. 1.13MB Share EMD EMD-RX5 demonstrates excellent safety and bioavailability 25/05/22 PRICE SENSITIVE download Created with Sketch. 1.17MB Share EMD Trading Halt 23/05/22 PRICE SENSITIVE download Created with Sketch. 242.03KB Share EMD Further positive MDMA analogue screening results received 10/05/22 PRICE SENSITIVE download Created with Sketch. 691.73KB Share EMD Appendix 4C - Quarterly 27/04/22 PRICE SENSITIVE download Created with Sketch. 965.14KB Share EMD Emyria launches second ultra-pure CBD capsule 17/03/22 PRICE SENSITIVE download Created with Sketch. 255.24KB Share EMD EMD-RX5 program advancing Phase 1 clinical trials underway 17/03/22 PRICE SENSITIVE download Created with Sketch. 255.24KB Share EMD Recruitment commenced for EMD-RX5 Phase 1 Study 09/03/22 PRICE SENSITIVE download Created with Sketch. 134.96KB Share EMD Ethics approval received for EMD-RX5 Phase 1 Study 03/03/22 PRICE SENSITIVE download Created with Sketch. 135.53KB Share EMD Half Yearly Report and Accounts 28/02/22 PRICE SENSITIVE download Created with Sketch. 990.39KB Share EMD Emyria grows its novel MDMA-analogue library 22/02/22 PRICE SENSITIVE download Created with Sketch. 138.19KB Share EMD Appendix 4C - Quarterly 28/01/22 PRICE SENSITIVE download Created with Sketch. 590.41KB Share EMD Phase 1 trial commences Q1, 2022 for Emyrias ultra-pure CBD 20/01/22 PRICE SENSITIVE download Created with Sketch. 269.86KB Share EMD Emyria adds wearables to psychedelic-assisted therapy trials 20/12/21 PRICE SENSITIVE download Created with Sketch. 167.02KB Share EMD Trading Halt 16/12/21 PRICE SENSITIVE download Created with Sketch. 696.42KB Share EMD Pause in Trading 16/12/21 PRICE SENSITIVE download Created with Sketch. 115.5KB Share EMD Positive animal data for Emyrias ultra-pure CBD capsule 15/12/21 PRICE SENSITIVE download Created with Sketch. 236.96KB Share
(20min delay)
